Recent Blog Posts

View Post: PrimeCuts: This Week in the Journals
Clinical Correlations
23 Nov 2009 by Clinical Correlations   ...
View Blog: http://www.clinicalcorrelations.org/

---

View Post: Jan Schlichtmann Discusses Amgen Qui Tam - Legal Broadcast Network ...
6 hours ago by The LBN Team  
Aranesp (darbepoetin alfa) is an injectable drug developed and manufactured by Amgen to stimulate and boost production of red blood cells in the body. Approved by the FDA in 2001 to treat anemia from chronic renal failure and in 2002 to ...
View Blog: News from the Legal Broadcast Network - http://blog.legalbroadcastnetwork.com/

---

View Post: A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney ...
2 Nov 2009 by noreply@blogger.com (Olique Estefan)  
Background Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, ...
View Blog: Need Free Content - http://regionmap.blogspot.com/

---

View Post: Partnering Profiles: Amgen
19 Nov 2009 by silico  
KA has given Amgen exclusive licenses to to manufacture and market: (i) darbepoetin alfa in the United States, Europe, Canada, Australia, New Zealand, Mexico, all Central and South American countries and certain countries in Central ...
View Blog: Silico Research - http://silico.wordpress.com/

---

View Post: A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney ...
3 Nov 2009 by Pfeffer MA, Burdmann EA, Chen CY, Cooper...  
Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested. METHODS: In this study involving 4038 patients with diabetes, chronic kidney disease ...
View Blog: JournalFeeds - http://journalfeeds.com/

---

View Post: Darbepoetin alfa is unsafe as well?
2 Nov 2009 by admin  
Darbepoetin alfa is a an erythropoesis stimulating agent marketed under the name Aranesp by AMGEN. It is used for the treatment of anemia ( a lower than normal blood count) as a consequence of renal failure or cancer. ...
View Blog: All Kidney News - http://www.allkidney.com/

---